Table of Content

  1. INTRODUCTION
    1. Study Assumptions and Market Definition
    2. Scope of the Study
  2. RESEARCH METHODOLOGY
  3. EXECUTIVE SUMMARY
  4. MARKET DYNAMICS
    1. Market Overview
    2. Market Drivers
      1. Increasing Number of Clinical Trials Resulting in Increased Outsourcing to CROs
    3. Market Restraints
      1. Regulatory Challenges
      2. Data Security Concerns
    4. Market Opportunities
      1. increasing Focus on Decentralized and Virtual Clinical Trials
    5. Market Trends
      1. Specialization in Niche Therapeutic Areas
      2. Real-world Evidence (RWE) Integration
  5. MARKET SEGMENTATION
    1. By Type
      1. Clinical Research Services
      2. Early Phase Development Services
      3. Laboratory Services
      4. Consulting Services
      5. Data Management Services
    2. By Clinical Research Services
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. By Early Phase Development Services
      1. Chemistry, Manufacturing and Control Services
      2. Preclinical Services
      3. Pharmacokinetics/Pharmacodynamics Services
      4. Toxicology Testing Services
      5. Other Preclinical Services
      6. Discovery Studies
    4. By Laboratory Services
      1. Analytical Testing Services
        1. Physical Characterization Services
        2. Raw Material Testing Services
        3. Batch Release Testing Services
        4. Stability Testing Services
        5. Other Analytical Testing Services
      2. Bioanalytical Testing Services
    5. By Therapeutic Area
      1. Oncology
      2. CNS Disorder
      3. Cardiology
      4. Infectious Diseases
      5. Immunological Diseases
      6. Respiratory Diseases
      7. Dermatology
      8. Ophthalmology
      9. Others
    6. By Key Geographic Regions
      1. North America
        1. United States
        2. Canada
        3. Mexico
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
      3. Asia Pacific
        1. China
        2. Japan
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia Pacific
      4. Middle East and Africa
        1. GCC
        2. South Africa
        3. Rest of Middle East and Africa
      5. South America
        1. Brazil
        2. Argentina
        3. Rest of South America
  6. COMPETITIVE LANDSCAPE
    1. Company Profile
      1. Charles River Laboratories International
      2. IQVIA
      3. ICON
      4. Laboratory Corporation of America Holdings
      5. Medpace Holdings
      6. PPD
      7. Syneos Health
      8. WuXi AppTec

7. MARKET OPPORTUNITIES AND FUTURE TRENDS



Frequently Asked Questions

Q.1. What is the projected market value of the global CRO (Contract Research Organization) servicesmarket?

The global market of CRO (Contract Research Organization) services is projected to reach USD 167.58 Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global CRO (Contract Research Organization) servicesmarket?

The global CRO (Contract Research Organization) services market has an estimated annual growth rate of 8.3% .

Q.3. What are the recent trends of CRO (Contract Research Organization) servicesmarket?

Specialization in niche therapeutic areasand Real-world Evidence (RWE) integrationare some of the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in CRO (Contract Research Organization) services?

 The major companies profiled in this report include Charles River Laboratories International, IQVIA, ICON, Laboratory Corporation of America Holdings, Medpace Holdings, PPD, Syneos Health, WuXi AppTec, among others.

Q.5. Which region is estimated to held highest CAGR inCRO (Contract Research Organization) servicesmarket?

North America is estimated to hold biggest share in the market for CRO (Contract Research Organization) services.

 

Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.